Mission
GENCURE IS ORGANIZED TO FOCUS ON REGENERATIVE MEDICINE AND THE UTILIZATION OF THE POWER OF HUMAN CELLS AND TISSUE TO ENHANCE LIVES AND ENABLE CLINICAL ADVANCEMENTS.
Public Charity
Gencure
Gencure, of SAN ANTONIO, TX, is a Public Charity tracked in Imperigo's IRS 990 database. The 2024 filing shows $5.4M in revenue, $16.0M in expenses, $23.7M in total assets. 7 publicly reported grants to this organization, totaling roughly $1.3M, appear in IRS filings.
EIN: 462216869
SAN ANTONIO, TX
Latest filing: 2024
Total Revenue$5.4M
Total Expenses$16.0M
Total Assets$23.7M
Grant Records7
Funding Total$1.3M
Filing Years2019–2024
Sample Grants Received
PROGRAM SUPPORT
$245,834
PROGRAM SUPPORT
$365,648
PROGRAM SUPPORT
$288,065
TEXAS CORD BLOOD BANK
$5,000
Texas Cord Blood Bank
$250,000
Showing up to 5 of 7 total records — full history available with membership.
Officers & Directors
Principal Global Market Development (effective 11/03/2024)
Amanda Whitelonis
SOLE MEMBER
Biobridge Global
General Manager, Biomanufacturing (thru 11/02/2024)
Geoffrey Kindt
SR. DIRECTOR, PROCESS DEV & CELL THERAPIES
Mari Lane Salmi
Director, Operations Biomanufacturing
Miguel Garza
VP, GENCURE OPERATIONS (thru 07/09/2024)
Milton Masayuki Pollard
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $5.4M | $16.0M | $23.7M |
| 2023 | $5.0M | $15.0M | $18.8M |
| 2022 | $5.0M | $13.7M | $21.8M |
| 2020 | $11.7M | $21.9M | $25.5M |
| 2019 | $15.4M | $21.8M | $26.6M |
Between 2019 and 2024, reported annual revenue declined from $15.4M to $5.4M (-65%), with total assets most recently reported at $23.7M.
Interactive year-over-year charts and full filing details available with membership.